Maximising Opportunities
Charlotte was Platelet Services’ first official employee and joined the company in 2020 following her studies in Manchester. Her appointment was supported by a grant from Nottingham Trent University and since joining, Charlotte has been developing her skills and expertise in platelets. In her blog, Charlotte explains how grasping the opportunity to join Platelet Services […]
Platelet Society Summer School: our post-event round up
Paul Cato had the pleasure of attending the Platelet Society Summer School last week on behalf of Platelet Services, which took place on the beautiful parkland campus at the University of Reading over the course of three days. In this post-event report, Paul shares some of his key takeaways from the event. About the […]
Returning to pharmacology
Wendy Tomlinson is Chief Scientific Officer at Platelet Services. In this blog she talks about her career and how it is possible to pursue a passion and path in science without taking the more traditional academic route. Wendy went to a secondary modern where O-Levels were not an option and girls did biology, boys did […]
Platelet function testing in drug discovery projects: considerations and challenges
Unwanted effects of drug compounds on platelet function can include a risk of increased bleeding and thrombotic events, depending on whether inhibition or enhancement of platelet function is involved. Despite these risks, drug-induced platelet function problems do not always appear to be identified in the drug discovery & development process and are sometimes reported late, […]
Blog: Tyrosine kinase inhibitors can have an effect on platelet function
Tyrosine kinase inhibitors (TKIs) are widely used as a targeted strategy for cancer treatment. However, due to their broad kinase target spectrum, most TKIs inevitably have off-target effects. Platelet function has been shown to be inhibited by TKIs, as they rely on the activity of several tyrosine kinases, including Tec, Btk, SFK, Lyn, Fyn, Syk. […]
